Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

2.970 +0.100 (+3.48%)

Streaming Delayed Price Updated: 9:35 AM EST, Feb 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

1 Nearly Unknown Biotech Stock Set To Go Parabolic If Its Pipeline Hits ↗

Today 3:35 EST

The company is studying its approved drug for many other indications.

Via The Motley Fool

IOVA Shares Jump 8% — What’s Retail Expecting? ↗

January 26, 2026

Iovance is a commercial stage immuno-oncology company seeking to deliver tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.

Via Stocktwits

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

As the final bells ring on Wall Street for 2025, the biotechnology sector is celebrating a dramatic reversal of fortune. After years of navigating high interest rates and regulatory uncertainty, the...

Via MarketMinute

Why Are IOVA Shares Rising Today? ↗

November 06, 2025

Via Stocktwits

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’ ↗

August 19, 2025

Via Stocktwits

The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal

December 30, 2025

As 2025 draws to a close, the global financial landscape is bracing for what analysts are calling an "Innovation Supercycle" in the mergers and acquisitions (M&A) market. With interest rates finally...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street ↗

December 29, 2025

Don't get too excited about their prospects.

Via The Motley Fool

Topics Death

2 Stocks That Could Soar by 52% and 282%, According to Wall Street ↗

December 07, 2025

This juicy upside potential comes at a cost.

Via The Motley Fool

Iovance (IOVA) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Iovance (IOVA) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Down 75% in 12 Months, Can Iovance Biotherapeutics Stock Turn Things Around? ↗

November 11, 2025

Iovance has a long way to go to get to a break-even point, but the company has been showing progress.

Via The Motley Fool

2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street ↗

November 07, 2025

Wall Street may be overestimating these companies' potential.

Via The Motley Fool

Top movers in Thursday's session ↗

November 06, 2025

Wondering how the US markets performed one hour before the close of the markets on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Top stock movements in today's session. ↗

November 06, 2025

Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 06, 2025

Via Benzinga

Gapping stocks in Thursday's session ↗

November 06, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Examining the Future: Iovance Biotherapeutics's Earnings Outlook ↗

November 05, 2025

Via Benzinga

Adaptimmune Plunges After Announcing Nasdaq Delisting Amidst Compliance Failures and Cost-Cutting Measures

October 20, 2025

Adaptimmune Therapeutics plc (NASDAQ: ADAP) has sent shockwaves through the biotechnology sector with its announcement on October 20, 2025, of a voluntary delisting of its American Depositary Shares...

Via MarketMinute

Topics Initial Public Offering Regulatory Compliance Workforce

Turnstone Biologics: A $100 Dream Collides with a $0.34 Reality

October 17, 2025

October 17, 2025 – In the volatile world of biotechnology, ambitious price targets often fuel investor speculation and market buzz. However, for Turnstone Biologics Corp. (NASDAQ: TSTN), the notion of...

Via MarketMinute

Topics Intellectual Property Workforce

Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health ↗

October 17, 2025

Is there a glimmer of hope for either of these underperforming healthcare companies?

Via The Motley Fool

Is Iovance Biotherapeutics Stock Your Ticket to Becoming a Millionaire? ↗

October 13, 2025

Investors have certainly seen explosive gains from shares of biopharma companies in similar situations.

Via The Motley Fool

Can This Beaten-Down Stock Bounce Back? ↗

September 19, 2025

This biotech company is innovative, but the market demands more than that.

Via The Motley Fool

If You'd Invested $1,000 in IOVA 3 Years Ago, Here's How Much You'd Have Today ↗

August 27, 2025

The company hasn't been popular among investors since winning its first FDA approval more than a year ago.

Via The Motley Fool

Why Iovance Biotherapeutics Stock Got Mashed on Monday ↗

August 25, 2025

The company announced a flotation of its common shares that is potentially quite dilutive.

Via The Motley Fool

Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday ↗

August 25, 2025

Via Benzinga

1 Beaten-Down Stock That Could Soar By 261%, According to Wall Street ↗

August 24, 2025

Time is running out for the company to mount a comeback.

Via The Motley Fool

Why Iovance Biotherapeutics Stock Was Climbing Today ↗

August 19, 2025

One and a half years after getting the nod from the U.S. Food and Drug Administration, its Amtagvi moves forward in a neighboring country.

Via The Motley Fool

Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday ↗

August 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 19, 2025

Via Benzinga

Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

August 19, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.